Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
424.9 USD | -1.17% | +3.75% | +4.60% |
11:53am | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
05-10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.60% | 111B | |
+10.71% | 105B | |
-12.22% | 22.34B | |
-3.55% | 21.93B | |
-5.85% | 18.59B | |
-36.52% | 18.12B | |
-9.80% | 16.96B | |
+3.24% | 13.7B | |
+37.03% | 12.45B | |
+297.37% | 7.98B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated, Q3 2016 Earnings Call, Oct 25, 2016